ConductScience.org, home

Paper38947111

Cancer to Cataracts: The Mechanistic Impact of Aldo-Keto Reductases in Chronic Diseases.

Shanbhag AP and 1 other. Yale J Biol Med, 2024. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Cancer to Cataracts: The Mechanistic Impact of Aldo-Keto Reductases in Chronic Diseases. Papers, record 38947111. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38947111

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cancer to Cataracts: The Mechanistic Impact of Aldo-Keto Reductases in Chronic Diseases.
PubMed
Journal
Yale J Biol Med
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.75, provisional
iCite
Revised in PubMed
2025-02-26
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shanbhag APAnirudh P
2Bhowmik PPurnendu

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Aldo-Keto ReductasesMajor topic
CataractMajor topic
NeoplasmsMajor topic
Humans
Chronic Disease

References115

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121276783Activities of aldo-keto reductase 1 enzymes on two inhaled corticosteroids: implications for the pharmacological effects of inhaled corticosteroids.Chem Biol Interact2011https://conductscience.org/library/papers/21276783PubMed
231271032Thymol Mediates Bactericidal Activity against Staphylococcus aureus by Targeting an Aldo-Keto Reductase and Consequent Depletion of NADPH.J Agric Food Chem2019https://conductscience.org/library/papers/31271032PubMed
312604219Aldo-keto reductases as modulators of stress response.Chem Biol Interact2003https://conductscience.org/library/papers/12604219PubMed
425304492The aldo-keto reductases (AKRs): Overview.Chem Biol Interact2015https://conductscience.org/library/papers/25304492PubMed
534884615Cytochrome P450 Enzymes and Drug Metabolism in Humans.Int J Mol Sci2021https://conductscience.org/library/papers/34884615PubMed
621255593Substrate specificity and inhibitor analyses of human steroid 5β-reductase (AKR1D1).Steroids2011https://conductscience.org/library/papers/21255593PubMed
722876234Aldo-Keto Reductases 1B in Endocrinology and Metabolism.Front Pharmacol2012https://conductscience.org/library/papers/22876234PubMed
827716796Functional Trade-Offs in Promiscuous Enzymes Cannot Be Explained by Intrinsic Mutational Robustness of the Native Activity.PLoS Genet2016https://conductscience.org/library/papers/27716796PubMed
915492289Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling.Cancer Res2004https://conductscience.org/library/papers/15492289PubMed
1029075254Babesia microti Aldo-keto Reductase-Like Protein Involved in Antioxidant and Anti-parasite Response.Front Microbiol2017https://conductscience.org/library/papers/29075254PubMed
1120628518Aldo-keto reductases in the eye.J Ophthalmol2010https://conductscience.org/library/papers/20628518PubMed
1215642094Computational prediction of human metabolic pathways from the complete human genome.Genome Biol2005https://conductscience.org/library/papers/15642094PubMed
1324917395Aldo-keto reductase 1C3 is overexpressed in skin squamous cell carcinoma (SCC) and affects SCC growth via prostaglandin metabolism.Exp Dermatol2014https://conductscience.org/library/papers/24917395PubMed
1425686905Acquisition of doxorubicin resistance facilitates migrating and invasive potentials of gastric cancer MKN45 cells through up-regulating aldo-keto reductase 1B10.Chem Biol Interact2015https://conductscience.org/library/papers/25686905PubMed
1528124606Cytochrome P450 Structure, Function and Clinical Significance: A Review.Curr Drug Targets2018https://conductscience.org/library/papers/28124606PubMed
1637335080A curated list of targeted optimized promiscuous ketoreductases (TOP-K).Biochem J2023https://conductscience.org/library/papers/37335080PubMed
1718616992Inactivation of the anticancer drugs doxorubicin and oracin by aldo-keto reductase (AKR) 1C3.Toxicol Lett2008https://conductscience.org/library/papers/18616992PubMed
1819011751Medium- and short-chain dehydrogenase/reductase gene and protein families : the MDR superfamily.Cell Mol Life Sci2008https://conductscience.org/library/papers/19011751PubMed
1924571686AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression.Diagn Pathol2014https://conductscience.org/library/papers/24571686PubMed
2034063865The Role of AKR1B10 in Physiology and Pathophysiology.Metabolites2021https://conductscience.org/library/papers/34063865PubMed

See all 115 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
41246341Lactylation-related gene AKR1A1 contributes to osteoporosis via metabolic-immune regulation: evidence from multi-omics integration, single-cell transcriptomics, and in vitro validation.Front Immunol2025https://conductscience.org/library/papers/41246341PubMed
41154825Aldose Reductase Involvement in EMT: Emerging Insights and Current Proposed Molecular Mechanisms.Biology (Basel)2025https://conductscience.org/library/papers/41154825PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38947111

GET https://conductscience.org/api/papers/v1/38947111/references?page=2